Clinical Trial Update: A Prospective, Double-Blinded, Randomized Controlled Trial of dHACM for Incisional Hernia Prophylaxis [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial is evaluating dHACM for prevention of incisional hernia, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Incisional Hernia

Drugs mentioned

• dHACM

Snippet

Sponsor: Louisiana State University Health Sciences Center in New Orleans | Conditions: Incisional Hernia | Phase 4 | Status: UNKNOWN